SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.
Jean W LiewMilena GianfrancescoCarly HarrisonZara IzadiStephanie RushSaskia Lawson-ToveyLindsay JacobsohnClairissa JaKimme L HyrichLaure GossecAnja StrangfeldLoreto CarmonaMartin SchaeferElsa Frãzao-MateusInita BulinaFrances StaffordAbdurrahman TufanChristine GraverGözde Kübra YardimciJulija ZepaSamar Al EmadiClaire CookFatemah AbutibanDfiza DeyGenevieve KatigbakLauren KaufmanEmily KowalskiMarco Ulises Martínez-MartínezNaomi J PatelGreta Reyes-CorderoEvelyn SalidoEllison SmithDavid SnowJeffrey A SparksLeanna WiseSuleman BhanaMonique Gore-MassyRebecca GraingerJonathan S HausmannEmily SirotichPaul SufkaZachary WallacePedro M MachadoPhilip C RobinsonJinoos YazdanyPublished in: RMD open (2022)
More than half of fully vaccinated individuals with breakthrough infections requiring hospitalisation were on BCDT or mycophenolate. Further risk mitigation strategies are likely needed to protect this selected high-risk population.